MCM
AMGN icon

Moore Capital Management’s Amgen AMGN Stock Holding History

Moore Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,462
Closed -$1.57M – 442
2023
Q4 		$1.57M Sell
5,462
-34,538
-86% -$9.41M 0.03% 249
2023
Q3 		$10.8M Buy
+40,000
New +$9.98M 0.2% 90
2016
Q1 		– Sell
-125,000
Closed -$20.3M – 237
2015
Q4 		$20.3M Buy
+125,000
New +$19.6M 0.63% 39
2014
Q3 		– Sell
-3,450
Closed -$408K – 401
2014
Q2 		$408K Hold
3,450
– – 0.01% 434
2014
Q1 		$426K Buy
+3,450
New +$418K 0.01% 397

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moore Capital Management's AMGN Position: Q1 2024 in Review

Moore Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 5,462 shares — an estimated $1.57M sold.

Moore Capital Management first reported a position in AMGN in Q1 2014 and held it in 5 quarters. The position peaked at $20.3M in Q4 2015. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Moore Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Moore Capital Management sold 5,462 Amgen shares in Q1 2024, an estimated $1.57M.
  • Moore Capital Management first reported a position in Amgen in Q1 2014 and held it in 5 quarters.
  • Moore Capital Management's Amgen position peaked at $20.3M in Q4 2015.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Moore Capital Management's 13F filing for Q1 2024, filed 15 May 2024.